At a time when congressional investigators are looking into the pricing practices of pharmaceutical companies, CHAS Fellow Rena M. Conti and her colleague Meredith B. Rosenthal review proposed policies for making prescription medications more affordable in the United States. Their article promotes the reform of specific pieces of legislature and also calls for a combination of coverage mandates and subsidies so as to ensure patients have access to necessary medications that may carry above average costs. Ultimately the two conclude that additional incentives are necessary to stimulate pharmaceutical research without driving up the price of medications.
